Work

Approval of DFMO for high-risk neuroblastoma patients demonstrates a step of success to target MYC pathway

Year: 2024

Type: article

Source: British Journal of Cancer

DOI: 10.1038/s41416-024-02599-6

Author: Jun Yang

Institutions: St. Jude Children's Research Hospital, University of Tennessee Health Science Center

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Health and Human Services, American Cancer Society, American Lebanese Syrian Associated Charities, National Institutes of Health, National Cancer Institute

Awards: G3829743247, G4534639002, G5775726095, G7283801956, Development of small molecules to target KDM4B, G8561966484, The functions of JMJD6 in MYC-mediated cancer, EXPLORE AND TARGET THE EPIGENETIC VULNERABILITY OF PAX3-FOXO1-DRIVEN RHABDOMYOSARCOMA

OpenAlex ID: W4391540946

FWCI: 4.791

Cites: 24

Cited by: 18

Related to: 10